Merit Medical Systems (NASDAQ:MMSI) Raised to Strong-Buy at Wall Street Zen

Merit Medical Systems (NASDAQ:MMSI) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a note issued to investors on Saturday.

A number of other equities analysts also recently weighed in on the company. Weiss Ratings restated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. BTIG Research started coverage on Merit Medical Systems in a research report on Friday, February 6th. They set a “buy” rating and a $107.00 price target for the company. Canaccord Genuity Group lifted their price target on Merit Medical Systems from $93.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Barrington Research boosted their price objective on Merit Medical Systems from $106.00 to $109.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Finally, Robert W. Baird set a $108.00 price objective on Merit Medical Systems in a research note on Tuesday, December 16th. Seven equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.25.

Merit Medical Systems Stock Performance

NASDAQ MMSI opened at $68.73 on Friday. The company has a fifty day moving average price of $76.85 and a 200-day moving average price of $82.17. The firm has a market cap of $4.08 billion, a price-to-earnings ratio of 32.42, a PEG ratio of 1.98 and a beta of 0.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95. Merit Medical Systems has a 1 year low of $66.34 and a 1 year high of $107.27.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a net margin of 8.48% and a return on equity of 13.82%. The company had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. During the same period last year, the firm earned $0.93 earnings per share. The firm’s revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, equities research analysts predict that Merit Medical Systems will post 3.37 EPS for the current fiscal year.

Institutional Investors Weigh In On Merit Medical Systems

Hedge funds have recently modified their holdings of the stock. Tudor Investment Corp ET AL bought a new position in Merit Medical Systems during the third quarter valued at $2,913,050,000. State Street Corp raised its stake in shares of Merit Medical Systems by 1.5% in the fourth quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock valued at $196,645,000 after buying an additional 32,459 shares during the period. Fuller & Thaler Asset Management Inc. lifted its position in shares of Merit Medical Systems by 12.7% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after buying an additional 234,682 shares during the last quarter. Maverick Capital Ltd. lifted its position in shares of Merit Medical Systems by 8.4% during the 2nd quarter. Maverick Capital Ltd. now owns 1,379,408 shares of the medical instruments supplier’s stock valued at $128,947,000 after buying an additional 106,897 shares during the last quarter. Finally, Wellington Management Group LLP grew its stake in shares of Merit Medical Systems by 7.0% during the 4th quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock worth $116,963,000 after acquiring an additional 86,504 shares during the period. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.